JP Morgan Chase
IPXL

JP Morgan Chase’s Impax Laboratories, Inc. IPXL Stock Holding History

JP Morgan Chase’s Portfolio IPXL Stock Details IPXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-35,000
Closed -$739K – 5699
2017
Q3 		$739K Buy
+35,000
New +$669K ﹤0.01% 3669

JP Morgan Chase's IPXL Position: Q2 2018 in Review

JP Morgan Chase sold out of Impax Laboratories, Inc. (IPXL) in Q2 2018, closing a stake of 459,229 shares — an estimated $8.93M sold.

JP Morgan Chase first reported a position in IPXL in Q2 2013 and held it in 20 quarters. The position peaked at $15.5M in Q2 2014. 1 fund tracked by Wall St. Rank holds IPXL as of Q2 2018.

  • JP Morgan Chase reported no remaining Impax Laboratories, Inc. position as of Q2 2018 after selling out during the quarter.
  • JP Morgan Chase sold 459,229 Impax Laboratories, Inc. shares in Q2 2018, an estimated $8.93M.
  • JP Morgan Chase first reported a position in Impax Laboratories, Inc. in Q2 2013 and held it in 20 quarters.
  • JP Morgan Chase's Impax Laboratories, Inc. position peaked at $15.5M in Q2 2014.
  • 1 fund tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2018.

Based on JP Morgan Chase's 13F filing for Q2 2018, filed 14 Aug 2018.